Ophthalmology

TSK Laboratory has a long-standing reputation for excellence in designing and manufacturing high-quality ophthalmic needles, syringes, and injection devices for the ophthalmology market. With decades of expertise, TSK has continuously pushed innovation in ophthalmic solutions, earning FDA 510(k) clearance for ophthalmic use. Among its leading products, the STERiJECT ophthalmic needles stand out for their precision and reliability, making them widely trusted by surgeons and clinicians worldwide.

STERiJECT ophthalmic needles have been featured in numerous scientific journals and are integrated into advanced surgical protocols, including the SAFER ROP protocol for Retinopathy of Prematurity and the Yamane technique for IOL. These applications highlight the versatility and clinical trust in STERiJECT technology.

What makes STERiJECT ophthalmic needles unique is their superior engineering. They feature rigid barrels that significantly reduce needle bending, ensuring precise control during delicate procedures. Their ultra-sharp bevels deliver exceptionally low penetration force, minimizing vitreous drag and enhancing patient outcomes. Extra-thin walls with large inner diameters provide optimal flow rates, while the low dead space design ensures less product loss in redundant space. This saves valuable product and enables more accurate dose injections.

With a proven track record, TSK Laboratory’s ophthalmic needles continue to set the standard in ophthalmology, combining innovation, safety, and performance trusted in critical eye procedures worldwide.